Omada Health (NASDAQ:OMDA) Stock Gets Price Target Trim from Barclays

Omada Health (NASDAQ:OMDA) had its price objective decreased by Barclays from $27.00 to $24.00 in a research report released on Wednesday morning,Benzinga reports. Barclays currently has an overweight rating on the stock.

A number of other research analysts have also recently commented on OMDA. Weiss Ratings cut Omada Health from a “sell (d+)” rating to a “sell (d)” rating in a research note on Thursday, October 8th. Needham & Company LLC reiterated a “buy” rating and issued a $28.00 target price on shares of Omada Health in a research note on Friday, September 11th. Canaccord Genuity Group lifted their target price on Omada Health from $24.00 to $28.00 and gave the stock a “buy” rating in a research report on Tuesday, July 21st. BTIG Research reiterated a “buy” rating and set a $35.00 target price on shares of Omada Health in a research report on Friday, September 11th. Finally, Robert W. Baird boosted their target price on shares of Omada Health from $15.00 to $25.00 and gave the company a “neutral” rating in a research note on Wednesday, August 12th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Omada Health has a consensus rating of “Moderate Buy” and a consensus price target of $26.42.

Omada Health Stock Performance

NASDAQ:OMDA opened at $18.73 on Wednesday. The firm has a market capitalization of $1.15 billion, a PE ratio of 245.62 and a beta of 2.03. The stock’s fifty day moving average is $20.75 and its 200 day moving average is $17.69. Omada Health has a fifty-two week low of $10.28 and a fifty-two week high of $26.13.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The business had revenue of $87.83 million for the quarter, compared to analysts’ expectations of $80.93 million. Equities analysts forecast that Omada Health will post 0.09 EPS for the current year.

Insider Buying and Selling at Omada Health

In other news, President Wei-Li Shao sold 4,036 shares of the business’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $21.85, for a total value of $88,186.60. Following the completion of the sale, the president owned 295,313 shares in the company, valued at approximately $6,452,589.05. The trade was a 1.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Sean P. Duffy sold 17,258 shares of the business’s stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $20.68, for a total transaction of $356,895.44. Following the completion of the sale, the chief executive officer owned 382,594 shares of the company’s stock, valued at approximately $7,912,043.92. This represents a 4.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 127,642 shares of company stock valued at $2,915,201 in the last ninety days. 6.38% of the stock is owned by insiders.

Hedge Funds Weigh In On Omada Health

Several institutional investors have recently bought and sold shares of the business. BlackRock Inc. purchased a new position in Omada Health during the 2nd quarter worth $48,775,000. Jefferies Financial Group Inc. purchased a new stake in Omada Health in the second quarter valued at about $15,016,000. Madryn Asset Management LP purchased a new stake in Omada Health in the second quarter valued at about $12,814,410. Walleye Capital LLC acquired a new stake in Omada Health in the second quarter worth about $11,648,000. Finally, Bank of America Corp DE acquired a new stake in Omada Health in the second quarter worth about $6,880,000.

About Omada Health

Omada Health, Inc (NASDAQ: OMDA) is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines personalized health coaching, clinical support, behavioral-change tools and connected devices to help members monitor and improve their health.

The company’s offerings focus primarily on cardiometabolic conditions, including diabetes, prediabetes, hypertension and obesity, as well as musculoskeletal conditions. Depending on the program, members may receive access to digital lessons, health tracking, remote monitoring, care teams and clinical guidance through Omada’s technology platform.

Omada Health was founded in 2011 and serves employers, health plans and other healthcare organizations in the United States.